
Join to view full profile
1365 Clifton Rd NeAtlanta, GA 30322
Phone+1 404-778-3444
Fax+1 404-778-3495
Dr. Fournier is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterResidency, Neurology, 2008 - 2011
St Elizabeth's Medical CenterInternship, Internal Medicine, 2007 - 2008
Medical College of Georgia at Augusta UniversityClass of 2007
Certifications & Licensure
GA State Medical License 2011 - 2026
NC State Medical License 2020 - 2022
AL State Medical License 2020 - 2020
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (All CQM's), Cerner Corporation, 2017
- CMS Meaningful Use Stage 1 Certification FirstNet (Clinical), Cerner Corporation, 2017
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2017
Publications & Presentations
PubMed
- Prospective Validation of the New PLS Diagnostic Criteria From PLS Natural History Study: EMG and Neurofilament Analyses.Eric Sorenson, Daragh Heitzman, Ikjae Lee, Grace Jang, Lauren Elman
Muscle & Nerve. 2026-06-01 - Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis.Tanner Michaelis, Cecilia S Lindestam Arlehamn, Emil Johansson, April Frazier, Gregory P Williams
Nature. 2026-04-01 - 1 citationsPrimary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment.Ikjae Lee, Grace Jang, Ying Kuen Ken Cheung, Alexander V Sherman, Wendy S Johnston
Annals of Neurology. 2026-02-01
Journal Articles
- Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Michael A Elliott, Samuel Maiser, Margaret A Owegi, Stephen A Goutman, Carlayne E Jackson, Jeffrey D Rothstein, Edward J Kasarskis, Liberty Jenkins, ..., The New England Journal of Medicine
Press Mentions
Long-Term Use of IV Edaravone Shows No Significant Slowing of ALS ProgressionJanuary 27th, 2022
ALS: Edaravone Addition to Riluzole Does Not Change Disease ProgressionJanuary 11th, 2022
Does Edaravone Slow ALS Progression?January 10th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









